Cargando…

Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study

PURPOSE: To investigate whether low complement levels can predict worse outcomes in patients hospitalized with positive anti-phospholipid antibodies. METHODS: This was a retrospective cohort study. We obtained demographics, laboratory, and prognostic data of all consecutive patients hospitalized bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itelman, Edward, Perelman, Maxim, Bivar, Natali, Kent, Daniella, Vaisman, Adva, Segal, Gad, Negru, Liat, Dagan, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155279/ https://www.ncbi.nlm.nih.gov/pubmed/36951167 http://dx.doi.org/10.1177/09612033231164091

Ejemplares similares

Mortality prediction upon hospital admission – the value of clinical assessment: A retrospective, matched cohort study
por: Glick, Noam, et al.
Publicado: (2022)

Do low levels of alanine aminotransferase, a baseline marker of sarcopenia and frailty, associate with worse clinical outcomes among hospitalized COVID-19 patients? A Retrospective Cohort Study
por: Gatt, Ehud Raz, et al.
Publicado: (2023)

Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients
por: Laufer, Menachem, et al.
Publicado: (2023)

Low ALT Levels Associated with Poor Outcomes in 8700 Hospitalized Heart Failure Patients
por: Segev, Amitai, et al.
Publicado: (2020)

Assessing the Usability of a Novel Wearable Remote Patient Monitoring Device for the Early Detection of In-Hospital Patient Deterioration: Observational Study
por: Itelman, Edward, et al.
Publicado: (2022)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019)

Sarcopenia as Manifested by L3SMI Is Associated with Increased Long-Term Mortality amongst Internal Medicine Patients—A Prospective Cohort Study
por: Portal, Doron, et al.
Publicado: (2022)

Remote Auscultation of Heart and Lungs as an Acceptable Alternative to Legacy Measures in Quarantined COVID-19 Patients—Prospective Evaluation of 250 Examinations
por: Haskel, Or, et al.
Publicado: (2022)

Hyperferritinemia in the elderly can differentiate the bad from the worst: A retrospective cohort analysis
por: Goldhaber, Gal, et al.
Publicado: (2020)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Low ALT, a marker of sarcopenia and frailty, is associated with shortened survival amongst myelodysplastic syndrome patients: A retrospective study
por: Uliel, Noa, et al.
Publicado: (2023)

Disability Progression in Multiple Sclerosis Is Affected by the Emergence of Comorbid Arterial Hypertension
por: Dagan, Amir, et al.
Publicado: (2016)

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
por: Barratt-Due, Andreas, et al.
Publicado: (2016)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Avascular osteonecrosis mechanism – between osteoporosis and antiphospholipid syndrome
por: Negru, Anca Ruxandra, et al.
Publicado: (2014)

The ‘SILENT Alarm’: When History Taking Reveals a Potentially Fatal Toxicity
por: Anani, Sapir, et al.
Publicado: (2018)

Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
por: Holers, V. Michael, et al.
Publicado: (2002)

Developing and validating a machine learning prognostic model for alerting to imminent deterioration of hospitalized patients with COVID-19
por: Kogan, Yuri, et al.
Publicado: (2022)

Pulmonary Hypertension Is Associated With Systemic Arterial Hypertension Among Patients With Normal Left Ventricular Diastolic Function
por: Itelman, Edward, et al.
Publicado: (2021)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023)

Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome
por: Killian, Martin, et al.
Publicado: (2022)

Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
por: Nalli, Cecilia, et al.
Publicado: (2021)

Natural antibodies and antiphospholipid antibodies bind to injured tissues, activate complement and cause tissue damage
por: Tsokos, G, et al.
Publicado: (2003)

Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003)

Do IgA antiphospholipid antibodies have any clinical importance?
por: Gaspersic, GN, et al.
Publicado: (2002)

A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding
por: Lim, William, et al.
Publicado: (2021)

Complement the cell death
por: Yeo, Joo Guan, et al.
Publicado: (2016)

Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
por: Lonati, Paola Adele, et al.
Publicado: (2019)

Complement-Mediated Thrombotic Microangiopathy in a Patient With Antiphospholipid Syndrome and Anti-glomerular Basement Membrane Antibodies
por: Gallant, Tara L, et al.
Publicado: (2023)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
por: Youkhana, Kimberley, et al.
Publicado: (2023)

Vomiting and Hyponatremia Are Risk Factors for Worse Clinical Outcomes Among Patients Hospitalized Due to Nonsurgical Abdominal Pain: A Retrospective Cohort Study
por: Goren, Idan, et al.
Publicado: (2016)

Antiphospholipid antibodies: Paradigm in transition
por: Horstman, Lawrence L, et al.
Publicado: (2009)

Inhibition of complement activation: a novel mechanism for the protective effects of heparin in antiphospholipid antibody-induced pregnancy loss
por: Girardi, G, et al.
Publicado: (2004)

CD8+DR+ T-Cells and C3 Complement Serum Concentration as Potential Biomarkers in Thrombotic Antiphospholipid Syndrome
por: Sarmiento, Elizabeth, et al.
Publicado: (2014)

Causes of Death in HIV-infected Persons Who Have Tuberculosis, Thailand
por: Cain, Kevin P., et al.
Publicado: (2009)

Commentary: Managing catastrophic antiphospholipid syndrome—do we have a way out?
por: Hirji, Sameer A., et al.
Publicado: (2021)

Is It Antiphospholipid Syndrome?
por: Ditto, Maria Chiara, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1ssh35dvm67enpodq891ekcvfn